Nitric oxide participation during amoebic liver abscess development;Participacion del oxido nitrico durante el desarrollo del absceso hepatico amebiano

Medicina

Volumn 67, Issue 2, 2007, Pages 167-176

  Ramirez Emiliano, Joel ^a   Flores Villavicencio, Lerida Liss ^a   Segovia, Jose ^b   Arias Negrete, Sergio ^a  

^a UNIVERSITY OF GUANAJUATO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Amoebiasis; Amoebic liver abscess; Entamoeba histolytica; Inducible nitric oxide synthase; Nitric oxide

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

AMEBIASIS; ARTICLE; ENTAMOEBA HISTOLYTICA; GROWTH INHIBITION; HAMSTER; HUMAN; IMMUNE SYSTEM; INFECTION RESISTANCE; INFECTION SENSITIVITY; LIVER AMEBIASIS; MAMMAL; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PATHOPHYSIOLOGY;

ANIMALS; CRICETINAE; DISEASE MODELS, ANIMAL; ENTAMOEBA HISTOLYTICA; HUMANS; IMMUNE SYSTEM; LIVER ABSCESS, AMEBIC; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 34249681759     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (99)

1. Janssens S, Beyaert R. Role of Toll-like receptors in pathogen recognition. Clin Microbiol Rev 2003; 16: 637-46.
2. Hallman M, Ramet M, Ezekowitz RA. Toll-like receptors as sensors of pathogens. Pediatr Res 2001; 50: 315-21.
3. Michelsen KS, Doherty TM, Shah PK, Arditi M. TLR signaling: An emerging bridge from innate immunity to atherogenesis. J Immunol 2004; 173: 5901-7.
4. Nagy LE. Recent Insights into the role of the innate immune system in the development of alcoholic liver disease. Exp Biol Med 2003; 228: 882-90.
5. Imler JL, Hoffmann JA. Toll receptors in Drosophila: a family of molecules regulating development and immunity. Curr Top Microbiol Immunol 2002; 270: 63-79.
6. Liew FY, Cox FE. Nonspecific defence mechanism: the role of nitric oxide. Immunol Today 1991; 12: A17-A21.
7. Green SJ, Scheller LF, Marietta MA, et al. Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens. Immunol Lett 1994; 43: 87-94.
8. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med 1994; 120: 227-37.
9. Jacobs P, Radzioch D, Stevenson MM. Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice. J Immunol 1995; 155: 5306-13.
10. Wheeler MA, Smith SD, Garcia-Cardena G, Nathan CF, Weiss RM, Sessa WC. Bacterial infection induces nitric oxide synthase in human neutrophils. J Clin Invest 1997; 99: 110-6.
11. Perez-Fuentes R, Sanchez-Guillen MC, Gonzalez-Alvarez C, Monteon VM, Reyes PA, Rosales-Encina JL. Humoral nitric oxide levels and antibody immune response of symptomatic and indeterminate Chagas' disease patients to commercial and autochthonous Trypanosoma cruzi antigen. Am J Trop Med Hyg 1998; 58: 715-20.
12. Sasaki S, Miura T, Nishikawa S, Yamada K, Hirasue M, Nakane A. Protective role of nitric oxide in Staphylo-coccus aureus Infection in mice. Infect Immun 1998; 66: 1017-22.
13. Khan IA, Schwartzman JD, Matsuura T, Kasper LH. A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc Natl Acad Sci USA 1997; 94: 13955-60.
14. Packer MA, Porteous CM, Murphy MP. Superoxide production by mitochondria in the presence of nitric oxide forms peroxynitrite. Biochem Mol Biol Int 1996; 40: 527-34.
15. Christopherson KS, Bredt DS. Nitric oxide in excitable tissues: physiological roles and disease. J Clin Invest 1997; 100: 2424-9.
16. Kanski J, Hong SJ, Schoneich C. Proteomic analysis of protein nitration in aging skeletal muscle and identification of nitrotyrosine-containing sequences in vivo by nanoelectrospray ionization tandem mass spectrometry. J Biol Chem 2005; 280: 24261-6.
17. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
18. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987; 61: 866-79.
19. Kelm M, Schrader J. Control of coronary vascular tone by nitric oxide. Circ Res 1990; 66: 1561-75.
20. Wood J, Garthwaite J. Models of the diffusional spread of nitric oxide: implications for neural nitric oxide signalling and its pharmacological properties. Neurophar-macology 1994; 33: 1235-44.
21. Liu X, Miller MJS, Joshi MS, Sadowska-Krowicka H, Clark DA, Lancaster Jr JR. Diffusion-limited reaction of free nitric oxide with erythrocytes. J Biol Chem 1998; 273: 18709-13.
22. 2. Proc Natl Acad Sci USA 2001; 98: 355-60.
23. Moncada S, Higgs A, Furchgott R. XIV International Union of Pharmacology Nomenclature in Nitric Oxide Research. Pharmacol Rev 1997; 49: 137-42.
24. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001; 357: 593-615.
25. Marietta MA. Nitric oxide synthase: aspects concerning structure and catalysis. Cell 1994; 78: 927-30.
26. Cho HJ, Xie QW, Calaycay J, et al. Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med 1992; 176: 599-604.
27. Cooke JP, Dzau VJ. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997; 48: 489-509.
28. Lee S-J, Stull JT. Calmodulin-dependent regulation of inducible and neuronal nitric-oxide synthase. J Biol Chem 1998; 273: 27430-37.
29. Searles CD, Miwa Y, Harrison DG, Ramasamy S. Post-transcriptional regulation of endothelial nitric oxide synthase during cell growth. Circ Res 1999; 85: 588-95.
30. Caillol M, Devinoy E, Lacroix MC, Schirar A. Endothelial and neuronal nitric oxide synthases are present in the suprachiasmatic nuclei of syrian hamsters and rats. Eur J Neurosci 2000; 12: 649-61.
31. Bult H, Boeckxstaens GE, Pelckmans PA, Jordaens FH, Van Maercke YM, Herman AG. Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotrans-mitter. Nature 1990; 345: 346-7.
32. Bredt DS, Snyder SH. Nitric oxide, a novel neuronal messenger. Neuron 1992; 8: 3-11.
33. Ishii K, Chang B, Kerwin JFJ, Wagenaar FL, Huang ZJ, Murad F. Formation of endothelium-derived relaxing factor in porcine kidney epithelial LLC-PK1 cells: an intra- and intercellular messenger for activation of soluble guanylate cyclase. J Pharmacol Exp Ther 1991; 256: 38-43.
34. Shankar R, Zhu J-S, Ladd B, Henry D, Shen H-Q, Baron AD. Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action. J Clin Invest 1998; 102: 1403-12.
35. Brown GC, Foxwell N, Moncada S. Transcellular regulation of cell respiration by nitric oxide generated by activated macrophages. FEBS Lett 1998; 439: 321-4.
36. Brookes PS, Kraus DW, Shiva S, et al. Control of mitochondrial respiration by NO. Effects of low oxygen and respiratory state. J Biol Chem 2003; 278: 31603-9.
37. Saavedra-Molina A, Ramirez-Emiliano J, Clemente-Guerrero M, Perez-Vazquez V, Aguilera-Aguirre L, Gonzalez-Hernandez JC. Mitochondrial nitric oxide inhibits ATP synthesis. Effect of free calcium in rat heart. Amino Acids 2003; 24: 95-102.
38. Schild L, Reinheckel T, Reiser M, Horn TFW, Wolf G, Augustin W. Nitric oxide produced in rat liver mito-chondria causes oxidative stress and impairment of respiration after transient hypoxia. FASEB J 2003; 17: 2194-201.
39. Manzo-Avalos S, Perez-Vazquez V, Ramirez J, et al. Regulation of the rate of synthesis of nitric oxide by Mg(2+) and hypoxia. Studies in rat heart mitochondria. Amino Acids 2002; 22: 381-9.
40. Ari G, Vardi Y, Finberg JP. Nitric oxide and penile erection in streptozotocin-diabetic rats. Clin Sci (Lond) 1999; 96: 365-71.
41. Eve DJ, Nisbet AP, Kingsbury AE, et al. Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease. Brain Res Mol Brain Res 1998; 63: 62-71.
42. Tieu K, Ischiropoulos H, Przedborski S. Nitric oxide and reactive oxygen species in Parkinson's disease. IUBMB Life 2003; 55: 329-35.
43. Perez-Severiano F, Escalante B, Vergara P, Rios C, Segovia J. Age-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntington's disease mutation. Brain Res 2002; 951: 36-42.
44. Gargiulo L, Bermejo M, Liras A. Reduced neuronal nitric oxide synthetase and c-protein kinase levels in Alzheimer's disease. Rev Neurol 2000; 30: 301-3.
45. Selley ML. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentra-tions of nitric oxide in the plasma of patients with Alzheimer's disease. Neurobiol Aging 2003; 24: 903-7.
46. Acar G, Idiman F, Idiman E, Kirkali G, Cakmakci H, Ozakbas S. Nitric oxide as an activity marker in multiple sclerosis. J Neurol 2003; 250: 588-92.
47. Ackers J, Mirelman D. Report on the 2nd EMBO Workshop on "Pathogenesis of Amoebiasis: From Genomics to Disease" held at Ein Gedi, Israel, November 16-20, 2004. Exp Parasitol 2005; 110: 170-2.
48. Ramos F, Moran P, Gonzalez E, et al. Entamoeba histolytica and Entamoeba dispar: prevalence infection in a rural Mexican community. Exp Parasitol 2005; 110: 327-30.
49. Guvel S, Kilinc F, Kayaselcuk F, Tuncer I, Ozkardes H. Emphysematous pyelonephritis and renal amoebiasis in a patient with diabetes mellitus. Int J Urol 2003; 10: 404-6.
50. Bredin C, Margery J, Bordier L, et al. Diabetes and Amoebiasis: a high risk encounter. Diabetes Metab 2004; 30: 99-102.
51. Arias-Negrete S, Chadee K. Immunopathogenesis of Entamoeba histolytica. In: LJ. Paradisse, M. Bendinelli and H. Friedman (Eds). Enteric infections and immunity. New York: Plenum Press, 1996, p 207-26.
52. Espinosa-Cantellano M, Martinez-Palomo A. Pathogenesis of intestinal amebiasis: from molecules to disease. Clin Microbiol Rev 2000; 13: 318-31.
53. Montfort I, Olivos A, Perez Tamayo R. Phagocytosis and proteinase activity are not related to pathogenicity of Entamoeba histolytica. Arch Med Res 1992; 23: 177-9.
54. Walsh JA. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis 1986; 8: 228-38.
55. Walsh JA. Amebiasis in the world. Arch Invest Med (Mex) 1986; 17: 385-9.
56. Sundaram C, Prasad B, Bhaskar G, Lakshmi V, Murthy J. Brain abscess due to Entamoeba histolytica. J Assoc Physicians India 2004; 52: 251-2.
57. Lichtenstein A, Kondo AT, Visvesvara GS, et al. Pulmonary amoebiasis presenting as superior vena cava syndrome. Thorax 2005; 60: 350-2.
58. Petri WAJ, Snodgrass TL, Jackson TF, et al. Monoclonal antibodies directed against the galactose-binding lectin of Entamoeba histolytica enhance adherence. J Immunol 1990; 144: 4803-9.
59. Stanley SLJ, Zhang T, Rubin D, Li E. Role of the Entamoeba histolytica cysteine proteinase in amebic liver abscess formation in severe combined immunodeficient mice. Infect Immun 1995; 63: 1587-90.
60. Avila EE, Calderon J. Entamoeba histolytica trophozoites: a surface-associated cysteine protease. Exp Parasitol 1993; 76: 232-41.
61. Araiza-Orozco LM, Avila EE, Munoz ML, Arias-Negrete S. Entamoeba histolytica: surface proteolytic activity and its relationship with in vitro virulence. Folia Parasitol (Praha) 1999; 46: 161-7.
62. Rosales-Encina JL, Schlie-Guzman MA, Jimenez-Delgadill B, Talamas-Rohana P, Matluk MR. Purification and partial characterization of an hemolytic activity from Entamoeba histolytica. Arch Med Res 1992; 23: 243-8.
63. Rosales-Encina JL, Campos-Salazar MS, Rojkind Matluk M. Entamoeba histolytica collagen binding proteins. Arch Med Res 1992; 23: 109-13.
64. Padilla-Vaca F, Martinez-Gallardo N, Blanco-Labra A, Shmuely H, Mirelman D. Novel thermo-stable serine-metallo proteinase of Entamoeba histolytica. Arch Med Res 2000; 31: S221-S223.
65. Barrios-Ceballos MP, Martinez-Gallardo NA, Anaya-Velazquez F, Mirelman D, Padilla-Vaca F. A novel protease from Entamoeba histolytica homologous to members of the family S28 of serine proteases. Exp Parasitol 2005; 110: 270-5.
66. Tsutsumi V, Mena-Lopez R, Anaya-Velazquez F, Martinez-Palomo A. Cellular bases of experimental amebic liver abscess formation. Am J Pathol 1984; 117: 81-91.
67. Perez-Tamayo R, Martínez RD, Montfort I, Becker I, Tello E, Perez-Montfort R. Pathogenesis of acute experimental amebic liver abscess in hamsters. J Parasitol 1991; 77: 982-8.
68. Shibayama M, Campos-Rodriguez R, Ramirez-Rosales A, Martinez-Palomo A, Tsutsumi V. Morphological analysis of amebic liver abscess produced by intraperitoneal inoculation of Entamoeba histolytica trophozoites in hamsters. Arch Med Res 1997; 28: 207-10.
69. Ventura-Juarez J, Jarillo-Luna RA, Fuentes-Aguilar E, et al. Human amoebic hepatic abscess: in situ interactions between trophozoites, macrophages, neutrophils and T cells. Parasite Immunol 2003; 25: 503-11.
70. Yu Y, Chadee K. Entamoeba histolytica stimulates interleukin 8 from human colonic epithelial cells without parasite-enterocyte contact. Gastroenterology 1997; 112: 1536-47.
71. Yu Y, Chadee K. Secreted Entamoeba histolytica proteins stimulate interleukin-8 mRNA expression and protein production in human colonic epithelial cells. Arch Med Res 1997; 28: 223-4.
72. Lin JY, Chadee K. Macrophage cytotoxicity against Entamoeba histolytica trophozoites is mediated by nitric oxide from L-arginine. J Immunol 1992; 148: 3999-4005.
73. Lin JY, Seguin R, Keller K, Chadee K. Tumor necrosis factor alpha augments nitric oxide-dependent macro-phage cytotoxicity against Entamoeba histolytica by enhanced expression of the nitric oxide synthase gene. Infect Immun 1994; 62: 1534-41.
74. Jesch NK, Dorger M, Enders G, et al. Expression of inducible nitric oxide synthase and formation of nitric oxide by alveolar macrophages: an interspecies comparison. Environ Health Perspect 1997; 105: 1297-300.
75. Dorger M, Jesch NK, Rieder G, et al. Species differences in NO formation by rat and hamster alveolar macrophages in vitro. Am J Respir Cell Mol Biol 1997; 16: 413-20.
76. Jesch NK, Dorger M, Messmer K, Krombach F. Formation of nitric oxide by rat and hamster alveolar macrophages: an interstrain and interspecies comparison. Toxicol Lett 1998; 96-97: 47-51.
77. Ramírez-Emílíano J, González-Hernande A, Arias-Negrete S. Expression of inducible nitric oxide synthase mRNA and nitric oxide production during the develop-ment of liver abscess in hamster inoculated with Entamoeba histolytica. Curr Microbiol 2005; 50: 299-308.
78. Seydel KB, Li E, Swanson PE, Stanley SLJ. Human intestinal epithelial cells produce proinflammatory cytokines in response to infection in a SCID mouse-human intestinal xenograft model of amebiasis. Infect Immun 1997; 65: 1631-9.
79. Seydel KB, Smith SJ, Stanley SLJ. Innate immunity to amebic liver abscess is dependent on gamma interferon and nitric oxide in a murine model of disease. Infect Immun 2000; 68: 400-2.
80. Jarillo-Luna RA, Campos-Rodriguez R, Tsutsumi V. Entamoeba histolytica: immunohistochemical study of hepatic amoebiasis in mouse. Neutrophils and nitric oxide as possible factors of resistance. Exp Parasitol 2002; 101: 40-56.
81. Wang W, Keller K, Chadee K. Entamoeba histolytica modulates the nitric oxide synthase gene and nitric oxide production by macrophages for cytotoxicity against amoebae and tumour cells. Immunology 1994; 83: 601-10.
82. Campbell D, Gaucher D, Chadee K. Serum from Entamoeba histolytica-infected gerbils selectively suppresses T cell proliferation by inhibiting interleukin-2 production. J Infect Dis 1999; 179: 1495-501.
83. Rico G, Leandro E, Rojas S, Giménez JA, Kretschmer RR. The monocyte locomotion inhibitory factor produced by Entamoeba histolytica inhibits induced nitric oxide production in human leukocytes. Parasitol Res 2003; 90: 264-7.
84. Sánchez-Ramírez B, Ramirez-Gil M, Vázquez-Moctezuma I, Ramos-Martinez E, Talamas-Rohana P. Entamoeba histolytica: induction of cyclooxygenase-2 expression during amoebic liver abscess formation in hamsters (Mesocricetus auratus). Exp Parasitol 2004; 106: 119-25.
85. Okamoto H, Roman RJ, Kampine JP, Hudetz AG. Endotoxin augments cerebral hyperemic response to halothane by inducing nitric oxide synthase and cyclooxygenase. Anesth Analg 2000; 91: 896-903.
86. Rettori V, Lomniczi A, Elverdin JC, et al. Control of salivary secretion by nitric oxide and its role in neuroimmuno-modulation. Ann NY Acad Sci 2000; 917: 258-67.
87. Ghosh DK, Misukonis MA, Reich C, Pisetsky DS, Weinberg JB. Host response to infection: the role of CpG DNA in induction of cyclooxygenase 2 and nitric oxide synthase 2 in murine macrophages. Infect Immun 2001; 69: 7703-10.
88. Ishimura N, Bronk SF, Gores GJ. Inducible nitric oxide synthase upregulates cyclooxygenase-2 in mouse cholangiocytes promoting cell growth. Am J Physiol Gastrointest Liver Physiol 2004; 287: G88-G95.
89. Pacheco-Yepez J, Campos-Rodríguez R, Shibayama M, Ventura-Juárez J, Serrano-Luna J, Tsutsumi V. Entamoeba histolytica: production of nitric oxide and in situ activity of NADPH diaphorase in amebic liver abscess of hamsters. Parasitol Res 2001; 87: 49-56.
90. Sannella A, Gradoni L, Persichini T, Ongini E, Venturini G, Colasanti M. Intracellular release of nitric oxide by NCX 972, an NO-releasing metronidazole, enhances in vitro killing of Entamoeba histolytica. Antimicrob Agents Chemother 2003; 47: 2303-6.
91. Siman-Tov R, Ankri S. Nitric oxide inhibits cysteine proteinases and alcohol dehydrogenase 2 of Entamoeba histolytica. Parasitol Res 2003; 89: 146-9.
92. Acevedo JA, Pacheco-Yepez J, Serrano-Luna J, Espinosa-Cantella M, Tsutsumi V, Shibayama M. Experimental amebic liver abscess: in vivo localization of TNF-alpha. Arch Med Res 2000; 31: S98-S100.
93. Pérez-Fuentes R, del Carmen Sanche M, Velazquez-Rojas M, Salgado-Rosas H, Torres-Rasgado E, Tala-masRohana P. Increased nitric oxide levels in patients with acute intestinal amebiasis. Arch Med Res 2000; 31: S87-S8.
94. Hernández-Campos ME, Canipos-Rodriguez R, Tsutsumi V, et al. Nitric oxide synthase in Entamoeba histolytica: its effect on rat aortic rings. Exp Parasitol 2003; 104: 87-95.
95. Yoshida A, Koide Y, Uchijima M, Yoshida TO. Dissection of strain difference in acquired protective immunity against Mycobacterium bovis Calmette-Guerin bacillus (BCG). Macrophages regulate the susceptibility through cytokine network and the induction of nitric oxide synthase. J Immunol 1995; 155: 2057-66.
96. Darrah PA, Hondalus MK, Chen Q, Ischiropoulos H, Mosser DM. Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages. Infect Immun 2000; 68: 3587-93.
97. Goff WL, Johnson WC, Parish SM, Barrington GM, Tuo W, Valdez RA. The age-related immunity in cattle to Babesia bovis infection involves the rapid induction of interleukin-12, interferon-gamma and inducible nitric oxide synthase mRNA expression in the spleen. Parasite Immunol 2001; 23: 463-71.
98. Bansal D, Sehgal R, Chawla Y, Malla N, Mahajan RC. Cytokine mRNA expressions in symptomatic vs. asymptomatic amoebiasis patients. P arasite Immunol 2005; 27: 37-43.
99. Morán P, Rico G, Ramiro M, et al. Defective production of reactive oxygen intermediates (ROI) in a patient with recurrent amebic liver abscess. Am J Trop Med Hyg 2002; 67: 632-5.